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Abstract
Transcription factors (TFs) are multidomain proteins that play a critical role in orchestrating stem 
cell differentiation, but several limitations hinder the full potential of TF-based gene regulation. 
Here we report a unique strategy to emulate TFs and differentiate stem cells in a nonviral approach 
using an artificial, nanoparticle-based transcription factor called NanoScript. The Nano-Script 
platform consists of a gold nanoparticle functionalized with small molecules that mimic the 
various domains of TFs. As a result, NanoScript mimics the function and structure of TF proteins. 
Specifically, NanoScript was designed to regulate muscle cell differentiation by targeting 
myogenic regulatory factors (MRFs), which play an important role in inducing myogenesis. This 
NanoScript-MRF is stable in physiological environments, localizes within the nucleus, induces 
differentiation of adipose-derived mesenchymal stem cells into mature muscle cells in 7 days, and 
is naturally excreted from induced muscle cells. As such, NanoScript represents a safe and 
powerful tool for applications requiring gene manipulation.
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Stem cell engineering and cellular reprogramming for regenerative medicine holds 
tremendous potential for treating many debilitating diseases and degenerative disorders.1 As 
such, significant effort has been invested into developing methods to effectively control the 
differentiation of stem cells into specific lineages.2 To this end, a subset of proteins called 
transcription factors (TFs) have been identified as the critical elements that orchestrate stem 
cell differentiation and cellular reprogramming. 3 The multidomain structure of TFs is 
composed of three essential domains: (i) the DNA-binding domain (DBD) that binds to 
specific DNA sequences, (ii) an activation domain (AD) that recruits RNA polymerase II 
and other proteins to initiate transcriptional activity, and (iii) a nuclear localization domain 
to enable entry into the nucleus. Through the synergistic activity of these domains, TFs 
interact with DNA to regulate gene expression, which, in turn, regulates fundamental 
cellular behaviors and can also override cellular identity to reprogram or differentiate cells 
into specific lineages.4 For example, the process of generating muscle cells, known as 
myogenesis, is governed by a group of four TFs called myogenic regulatory factors (MRFs), 
which include MyoD, Myogenin, Myf5, and Mrf4, and have been demonstrated to play a 
critical role in generating muscle cells from both somatic and stem cells.5–7 As such, the 
modulation of MRFs holds tremendous potential to treat incurable degenerative muscle 
disorders, such as muscular dystrophy.8
To date, most conventional methods for inducing stem cell differentiation or cellular 
reprogramming have been developed to either (i) deliver gene-specific TF proteins into cells 
(using nanocarriers, electroporation, and liposomes)9–11 or (ii) stimulate the production of 
gene-specific TFs within the cells (using viral vectors and small molecules).12–14 However, 
these methods are limited due to inherent drawbacks such as low delivery efficiency, lack of 
cell/nuclear-targeting capabilities, minimal gene expression, random genomic integration, 
and vulnerability to intracellular degradation.15 Moreover, direct delivery of TF proteins into 
cells faces limitations, including intracellular degradation and low delivery efficiency, which 
leads to limited gene expression.16 Hence, there is an urgent need to develop an alternative 
approach that not only overcomes the limitation of conventional methods but also is capable 
of regulating gene expression and inducing stem cell differentiation in an effective and 
nonintegrative manner.16
To this end, we recently demonstrated that by assembling functional molecules onto gold 
nanoparticles (AuNPs), an artificial nanoparticle-based transcription factor, called 
NanoScript, could be developed for effective gene regulation.17 A remarkable feature of this 
NanoScript platform is its ability to behave and function just like natural TFs, as we recently 
demonstrated that NanoScript can initiate transcription of a reporter plasmid and overexpress 
targeted endogenous genes in a nonviral manner. While this proof-of-concept demonstration 
has established NanoScript as being capable of regulating gene expression, application of 
NanoScript for inducing stem cell differentiation remains unexplored. Due to the tunable 
properties of NanoScript, we hypothesize that this platform can be modified and utilized to 
mimic differentiation-specific TFs, such as MRFs, to induce stem cell differentiation.
In this report, we demonstrate that NanoScript can be designed to replicate natural TFs that 
are specific for myogenic regulatory factors (MRFs) (Figure 1). This NanoScript-MRF 
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efficiently penetrates the plasma membrane and, with the help of a nuclear-targeting peptide, 
can localize within the nucleus while remaining intact. Importantly, NanoScript-MRF can 
target and activate the four critical genes that regulate myogenesis, which include MyoD, 
Myogenin, Myf5, and Mrf, in a nonintegrative approach to successfully differentiate 
adipose-derived mesenchymal stem cells (ADMSCs) into muscle cells. The gene expression 
levels induced by NanoScript-MRF are comparable to and even exceed those of 
conventional TF–protein-based delivery methods. Finally, we show that NanoScript-MRF is 
naturally cleared from the induced muscle cells. In this way, we have developed a modified 
NanoScript platform to effectively induce stem cell differentiation. Moreover, NanoScript 
has tunable components that can easily be resequenced to target almost any gene of interest, 
and hence, it can mimic other transcription factors of interest.
RESULTS AND DISCUSSION
Design and Characterization of NanoScript-MRF
The Nano-Script platform, designed to replicate the multidomain structure of natural TFs, 
comprises several key components: (1) a hairpin polyamide small molecule that mimics the 
DBD, (2) a peptide that mimics the AD, (3) a cell-penetrating peptide (CPP) to facilitate 
entry into the cell and nucleus, (4) polyethylene glycol (PEG)-based molecules to increase 
the stability of NanoScript in physiological conditions, and (5) a gold nanoparticle that acts 
as the linker domain to tether these components.
The first small molecule that we synthesized was a hairpin polyamide DBD, which 
comprises pyrrole (Py) and imidazole (Im) motifs that complement the A–T and G–C DNA 
base pairs, respectively, and can be designed to target specific gene sequences.18,19 Natural 
MRFs activate muscle-specific transcription by binding to the DNA consensus sequence that 
is specific in the promoter region of all four MRF genes (Supporting Information Figure S1).
20
 Hence, using an established solid-phase synthesis procedure,21 we synthesized a hairpin 
polyamide DBD specific for MRFs (termed MRF-DBD) with the sequence PyPyPy-β-
PyPyIm-γ-PyPyPy-β-PyImPy-β-Dp (γ is γ-aminobutyric acid, β is β-alanine, and Dp is 
dimethylaminopropylamide) to complement the consensus promoter sequence (Figure 2a). 
After synthesis, we used surface plasmon resonance to confirm that the MRF-DBD had a 
strong binding affinity of 9.0×10−9 M to its target sequence (Figure 2b). Then, to represent 
the AD, we designed a peptide referred to as a transactivation peptide (TAP), which has been 
shown to act as a potent activator and inducer of transcriptional activity.22,23 Finally, an 
established CPP was designed to facilitate nuclear localization of NanoScript.24
In order for the NanoScript platform to behave and function like natural TFs, it must be 
highly soluble in aqueous solutions, stable in physiological conditions, and cannot form 
aggregates. For this purpose, PEG-based molecules are used because they significantly 
increase solubility of conjugated biomolecules and stabilize nanoparticles in physiological 
conditions.25 Furthermore, thiol-terminated PEG molecules enable functionalization of a 
mixed monolayer on AuNPs.24,26 Hence, we conjugated all three biomolecules (MRF-DBD, 
TAP, and CPP) to a thiol-terminated PEG molecule, and then the three PEG-conjugated 
biomolecules were mixed with 10 nm AuNPs to construct NanoScript-MRF (Figure 3a,b). 
Using a zetasizer, the hydrodynamic diameter of the final NanoScript-MRF was determined 
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to be 41.6 nm and the surface charge to be −41.2 mV (Figure 3c). Using high-performance 
liquid chromatography, the amount of ligands per gold nanoparticle was found to be 1297 
± 102 (Supporting Information Figure S2), which is in correlation with previous reports.27 
Furthermore, the solubility of NanoScript-MRF in physiological environments was 
evaluated by incubation in cell culture media for 7 days. Specifically, we found that the 
NanoSript-MRF maintained its monodisperse properties as compared to day 0 (Figure S3), 
thus confirming that NanoScript-MRF is suitable for cell applications.
NanoScript-MRF Localizes in the Nucleus
All transcriptional activity occurs exclusively inside the nucleus; hence, an important 
criterion for NanoScript to regulate gene expression is efficient membrane permeation and 
nuclear localization. To this end, we carefully ensured that NanoScript has two distinct 
features. The first feature is a specially designed CPP on NanoScript to facilitate permeation 
of both the plasma and the nuclear membrane.24,28 The second feature is that the 
hydrodynamic diameter is smaller than 44 nm, which is the size of the nuclear pore.29 Taken 
together, this ensures that NanoScript can specifically target and enter the nucleus.
NanoScript’s ability to permeate the plasma membrane was evaluated by incubating 
NanoScript-MRF with ADMSCs. In order to calculate the concentration of NanoScript to be 
incubated with the ADMSCs, we performed a dose-dependent cell viability assay that 
revealed that the highest concentration with the highest viability is 10 μg/mL, and hence, we 
used this concentration for all subsequent experiments (Supporting Information Figure S4). 
To monitor intracellular localization, NanoScript was modified with a fluorescent dye and 
incubated in ADMSCs. Fluorescence imaging confirmed that NanoScript was able to 
translocate within the nucleus, as evidenced by the overlap of the Alexa Fluor 568 dye 
(attached onto NanoScript) and 4′,6-diamidino-2-phenylindole (DAPI) (nucleus staining) 
(Supporting Information Figure S5). Overall, an analysis of the intracellular localization 
dynamics of NanoScript-MRF confirmed that the hydrodynamic size of NanoScript-MRF 
(diameter = ~40 nm) is small enough to enter and accumulate within the nucleus.
NanoScript Induces Myogenesis from Stem Cells
In order to establish the NanoScript platform for stem cell differentiation, we evaluated 
NanoScript’s ability to genetically reprogram ADMSCs into muscle cells.30 Even though 
NanoScript can be applied to almost any cell line, ADMSCs were chosen because they are 
an excellent model of multipotency, and depending on which genes are activated, ADMSCs 
can differentiate into multiple lineages including muscle, bone, fat, and even neuronal cells.
13,31,32
 Hence, we predicted that by activating MRFs in ADMSCs, particularly MyoD 
because it has been established as the most prominent myogenesis gene,7,33 using 
NanoScript-MRF, we can guide their differentiation to generate muscle cells. When we 
adopted a differentiation timeline from a previous report,13 ADMSCs were treated with 
Nano-Script-MRF by incubating them in the culture media,24 and then a myogenic medium 
was introduced to support muscle growth (Figure 4a). After 7 days, expression of muscle-
specific markers and phenotype changes was analyzed. As evidenced by the expression of 
Myogenin,34 a ubiquitous myogenic marker, and myosin,13 a distinct muscle marker, we 
observed generation of myocytes, which are elongated, tubular muscle fiber cells, using the 
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NanoScript-MRF platform (Figure 4b). This result was compared to the untreated control, 
which also included replacement with myogenic media and showed minimal expression of 
myogenic markers (Figure 4b). Additional control experiments evaluated the contribution of 
each domain on NanoScript. Because these control experiments, which included a 
NanoScript lacking an AD or MRF-DBD, were unable to significantly activate myogenic 
genes beyond basal levels, it signifies that the domains on NanoScript are important for 
initiating transcriptional activity (Supporting Information Figures S6 and S7). Furthermore, 
the induced myocytes displayed the unique phenotype of mature muscle fiber characteristics, 
as evidenced by the distribution of multiple nuclei and the formation of striations in the 
aligned muscle fiber. The formation of these striations, called myofibrils, was further 
observed in the fluorescence intensity profile, which showed six distinct peaks that represent 
individual myofibril filaments (Figure 4c).
This myogenic differentiation was further confirmed using qPCR to quantify the activation 
of muscle-specific genes. Two distinct intermediate myogenic genes, desmin and enolase,
13,35
 along with all four MRFs were effectively activated in cells treated with NanoScript-
MRF, as compared to the control (Figure 5a). Furthermore, the late-stage myocyte marker, 
myosin heavy chain (MYH1),36 was up-regulated by about 28-fold (Figure 5a). This 
evidence strongly suggests that the gene expression potency induced by NanoScript-MRF is 
sufficient to trigger downstream myogenic genes involved in generating and supporting 
myocyte growth. As a result of activating myogenic genes, multipotency genes distinct for 
ADMSCs were suppressed and significantly down-regulated, thus indicating that 
differentiated cells no longer genetically resemble ADMSCs (Figure 5b). Moreover, cell 
viability assays indicated the viability of generated muscle cells to be 97.6 ± 1.1% (statistics 
from three independent experiments), as compared to the untreated control. Furthermore, we 
tested if NanoScript had any adverse effects on the DNA, such as inducing double-strand 
breaks,37 using a commercially available staining kit, and we found that NanoScript does not 
generate double-stand breaks (Supporting Information Figure S8). Collectively, these 
findings establish that genetic reprogramming by NanoScript-MRF can initiate 
transcriptional activity of differentiation-specific genes in stem cells to generate muscle 
cells.
NanoScript-MRF Mimics the Functions of Natural Transcription Factors
Next, to validate our claim that NanoScript emulates the function of natural TFs, we 
compared our NanoScript to commercially available TF proteins, such as the MyoD-TF, 
which functions to regulate myogenesis. We transfected various concentrations of the 
MyoD-TF protein into ADMSCs following the protocol from a commercially available 
protein delivery kit, which is based upon conventional cationic-based lipids for transfection. 
After 7 days, we observed a dose-dependent increase of MyoD gene expression (Figure 6a); 
however, the expression was less than that induced by our NanoScript-MRF at a similar 
concentration. This result suggests that NanoScript effectively mimics the gene-regulating 
function of conventional TF proteins.
Patel et al. Page 5
ACS Nano. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
NanoScript Is Naturally Cleared from Cells
Finally, a strongly desired characteristic of differentiated cells is that they are free of any 
foreign or exogenously introduced materials. The movement of foreign cargo across the cell 
membrane is regulated by natural mechanisms called endocytosis and exocytosis (Figure 
6b). We wanted to ensure that the generated muscle cells did not contain any inorganic 
remnants from the gold nanoparticle core of NanoScript. To this end, we monitored the gold 
content in the cells throughout the differentiation period. Immediately after treatment of 
NanoScript, there was a significant increase in the number of NanoScript particles inside the 
cell, but by the end of the differentiation period on day 7, most of the NanoScript particles 
(~95%) were excreted from the cells (Figure 6c). This result as in agreement with previous 
reports that demonstrate exocytosis of gold nanoparticles.24,38 As a result of almost all gold 
remnants being excreted from the differentiated muscle cells, we believe that the NanoScript 
platform can be effectively utilized for stem cell applications.
CONCLUSIONS
In conclusion, we have successfully demonstrated that a completely artificial, nanoparticle-
based transcription factor called NanoScript can be designed to replicate the function of 
differentiation-specific TFs. Specifically, we developed a NanoScript specific for MRFs to 
induce muscle differentiation. NanoScript-MRF is stable in physiological environments, 
small enough to localize within the nucleus, efficient in targeting and activating MRF genes, 
potent enough to induce muscle differentiation of ADMSCs, and is safely cleared from 
differentiated cells. Moreover, considering that direct TF delivery is hindered by low 
transfection efficiency,39 our NanoScript-MRF mimicking the functions of natural TFs could 
be an alternative method for stem-cell-based regenerative medicine. Compared to natural 
TFs, our NanoScript platform has several distinct advantages, including the ability to mimic 
any TF protein by simply tuning one small molecule component; the multifunctional 
nanoparticle core can potentially be used for simultaneous imaging and tracking and the 
ability to localize with the nucleus due to a specific membrane-penetrating peptide, all of 
which leads to enhanced gene expression in a nonviral manner.
As the NanoScript platform regulates genes in a nonintegrative approach, it is a highly 
attractive tool for conventional gene-regulating methods. As such, we envision that the 
multifunctional surface of Nano-Script will allow for conjugation of other small molecules 
that can further enhance the gene-regulating capabilities of NanoScript and expand its scope 
of being utilized for stem cell applications. For example, addition of small molecule gene 
regulators, such as RNAi and oligonucleotides,40,41 or epigenetic modification molecules42 
onto NanoScript can potentially enhance its gene expression capabilities. Furthermore, by 
modifying the hairpin polyamide sequence, Nano-Script can easily be designed to target and 
activate almost any gene of interest, including differentiation-specific genes. Finally, the 
current gold nanoparticle core can easily be changed to another type, such as magnetic core–
shell nanoparticles or mesoporous silica nanoparticles, which can enable real-time in vivo 
tracking using magnetic resonance imaging and multifaceted delivery, respectively, without 
compromising the overall concept and design of NanoScript. As a result of these unique and 
remarkable features, we strongly believe that NanoScript represents a powerful tool to 
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replicate almost any TF for gene-regulating applications, including stem cell differentiation 
and cellular reprogramming.
METHODS
Construction of NanoScript
The NanoScript platform was constructed using a two-step method. First, the amine-
terminated biomolecules were conjugated to a linker molecule, SH-PEG-COOH [thiol-PEG-
carboxy 1kDa (Creative PEGWorks, PBL-8073)]. The PEG molecule was dissolved into a 
50mM ethanol solution. Then, 50 mM of 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide) 
(EDC) (Sigma) and 50mM of N-hydroxysuccinimide (NHS) (Acros Organics) was added to 
this solution and then placed on a shaker for 1 h to activate the carboxyl group. Afterward, a 
5mM solution of the three biomolecules (MRF-DBD, TAP, and CPP) was added to the 
solution and was allowed to react at room temperature for 2 h. A solution containing 10 
molar excess of PEG-MRF-DBD, PEG-TAP, and PEG-CPP with a mole ratio of 2:2:1 was 
added dropwise to the 10 nm AuNP solution and allowed to stir for 2 h. The functionalized 
AuNPs (termed NanoScript) were filtered three times using a 10 000 MCWO filter 
(Millipore) to remove unreacted molecules and to adjust the volume and concentration. The 
dye-labeled NanoScript, used for tracking intracellular localization of NanoScript, was 
constructed by conjugating the Alexa Fluor 594 (Invitrogen) fluorescent dye to TAP. 
Specifically, the free carboxy group on PEG-TAP was further conjugated to the Alexa Fluor 
594 hydrazide dye via EDC/NHS coupling as described above.
ADMSC Culture and Myogenic Differentiation
The human ADMSCs (American CryoStem) and the 0.5% fetal bovine serum growth media 
were provided by American CryoStem. All cell culture was performed using the 
manufacture’s protocol. The ADMSCs were grown on fibronectin-coated (2 μg/cm2, 
Millipore) culture dishes and maintained at 37 °C in a humidified incubator with 5% CO2. 
For consistency, all experiments were carried out on cells between passages 2 and 4. For 
myogenic differentiation experiments, ADMSCs were seeded in a 24-well plate at a density 
of 20 000 cells per well. After 24 h, 10 μg/mL of Nano-Script-MRF was incubated with the 
cells for 4 h. Thereafter, the cells were washed twice with PBS (phosphate-buffered saline), 
and myogenic medium was added. The myogenic growth media comprised 2% horse serum 
(Sigma), human transferrin (2.5 μg/mL, Sigma), human insulin (5 μg/mL, Life 
Technologies), and 1% penicillin and streptomycin (Life Technologies) in high glucose 
DMEM (Dulbecco’s modified Eagle medium, Invitrogen). A 10 μg/mL of NanoScript-MRF 
was transfected on day 2 for 4 h and washed twice with PBS, and then fresh myogenic 
medium was added. The cells were allowed to differentiate for 7 days in myogenic growth 
medium, which was replaced with fresh medium every other day. The MyoD-TF protein 
(Abcam, #ab134857) was transfected into ADMSCs on day 0 and day 2 using a 
commercially available kit (Thermo Scientific, Pro-Ject Protein Transfection Reagent 
#89850) and by following the manufacturer’s protocol.
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Immunocytochemistry
To investigate the nuclear localization of the dye-labeled NanoScript in ADMSCs, the 
medium was removed and the cells were fixed for 15 min in formalin (Sigma) followed by 
two washes with PBS. The nucleus was stained with DAPI (Life Technologies) for 30 min 
and then washed with PBS three times. To investigate the extent of myogenic differentiation, 
on day 7, the cells were fixed with formalin for 15 min and then washed twice with PBS. 
Cells were then permeabilized with 0.1% Triton X-100 in PBS for 10 min, and nonspecific 
binding was blocked with 5% normal goat serum (NGS, Life Technologies) in PBS for 1 h 
at room temperature. To study the extent of myogenic differentiation, the primary mouse 
antibody against myosin (1:200 dilution, Sigma) and the primary rabbit antibody against 
myogenin (1:200 dilution, Santa Cruz Biotechnology) was used. Following the 
manufacturer’s protocol, the fixed samples were incubated overnight at 4 °C in a solution of 
these antibodies in PBS containing 10% NGS. After being washed three times with PBS, the 
samples were incubated for 1 h at room temperature in a solution of anti-mouse secondary 
antibody labeled with Alexa Fluor 647 (1:100, Life Technologies), anti-rabbit secondary 
antibody labeled with Alexa Fluor 546 (1:100, Life Technologies), and DAPI (1:100, Life 
Technologies) in PBS containing 10% NGS. After being washed three times, all samples 
were imaged using a Nikon T2500 inverted fluorescence microscope.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We give special thanks to American CryoStem Corporation (Anthony Dudzinski, Ruth Goldman, and Michael 
Moeller) for providing the ADMSCs and cell media. We express gratitude to Prof. Gene Hall (Rutgers University) 
for assisting in ICP-OES measurements. This work was financially supported the NIH Director’s Innovator Award 
(1DP20D006462-01), the NIH R21 grant (1R21NS085569-01), the N.J. Commission on Spinal Cord grant 
(CSR13ERG005), and the Rutgers Busch Biomedical Grant Program.
REFERENCES AND NOTES
1. Wu SM, Hochedlinger K. Harnessing the Potential of Induced Pluripotent Stem Cells for 
Regenerative Medicine. Nat Cell Biol. 2011; 13:497–505. [PubMed: 21540845] 
2. Tabar V, Studer L. Pluripotent Stem Cells in Regenerative Medicine: Challenges and Recent 
Progress. Nat Rev Genet. 2014; 15:82–92. [PubMed: 24434846] 
3. Spitz F, Furlong EEM. Transcription Factors: From Enhancer Binding to Developmental Control. 
Nat Rev Genet. 2012; 13:613–626. [PubMed: 22868264] 
4. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A Census of Human Transcription 
Factors: Function, Expression and Evolution. Nat Rev Genet. 2009; 10:252–263. [PubMed: 
19274049] 
5. Sassoon D, Lyons G, Wright WE, Lin V, Lassar A, Weintraub H, Buckingham M. Expression of 
Two Myogenic Regulatory Factors Myogenin and MYODl during Mouse Embryogenesis. Nature. 
1989; 341:303–307. [PubMed: 2552320] 
6. Pownall ME, Gustafsson MK, Emerson CP. Myogenic Regulatory Factors and the Specification of 
Muscle Progenitors in Vertebrate Embryos. Annu Rev Cell Dev Biol. 2002; 18:747–783. [PubMed: 
12142270] 
Patel et al. Page 8
ACS Nano. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
7. Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, MacQuarrie KL, Davison J, Morgan 
MT, Ruzzo WL, et al. Genome-Wide MyoD Binding in Skeletal Muscle Cells: A Potential for 
Broad Cellular Reprogramming. Dev Cell. 2010; 18:662–674. [PubMed: 20412780] 
8. Tedesco FS, Gerli MFM, Perani L, Benedetti S, Ungaro F, Cassano M, Antonini S, Tagliafico E, 
Artusi V, Longa E, et al. Transplantation of Genetically Corrected Human iPSC-Derived Progenitors 
in Mice with Limb-Girdle Muscular Dystrophy. Sci Transl Med. 2012; 4:140ra89.
9. Choi SO, Kim YC, Lee JW, Park JH, Prausnitz MR, Allen MG. Intracellular Protein Delivery and 
Gene Transfection by Electroporation Using a Microneedle Electrode Array. Small. 2012; 8:1081–
1091. [PubMed: 22328093] 
10. Dimitrov, D. Therapeutic Proteins. Voynov, V., Caravella, JA., editors. Vol. 899. Humana Press; 
Totowa, NJ: 2012. p. 1-26.
11. Tang R, Kim CS, Solfiell DJ, Rana S, Mout R, Velázquez-Delgado EM, Chompoosor A, Jeong Y, 
Yan B, Zhu ZJ, et al. Direct Delivery of Functional Proteins and Enzymes to the Cytosol Using 
Nanoparticle-Stabilized Nanocapsules. ACS Nano. 2013; 7:6667–6673. [PubMed: 23815280] 
12. Darabi R, Arpke RW, Irion S, Dimos JT, Grskovic M, Kyba M, Perlingeiro RCR. Human ES- and 
iPS-Derived Myogenic Progenitors Restore Dystrophin and Improve Contractility upon 
Transplantation in Dystrophic Mice. Cell Stem Cell. 2012; 10:610–619. [PubMed: 22560081] 
13. Goudenege S, Pisani DF, Wdziekonski B, Di Santo JP, Bagnis C, Dani C, Dechesne CA. 
Enhancement of Myogenic and Muscle Repair Capacities of Human Adipose-Derived Stem Cells 
with Forced Expression of MyoD. Mol Ther. 2009; 17:1064–1072. [PubMed: 19352326] 
14. Albini S, Coutinho P, Malecova B, Giordani L, Savchenko A, Forcales SV, Puri PL. Epigenetic 
Reprogramming of Human Embryonic Stem Cells into Skeletal Muscle Cells and Generation of 
Contractile Myospheres. Cell Rep. 2013; 3:661–670. [PubMed: 23478022] 
15. Gu Z, Biswas A, Zhao M, Tang Y. Tailoring Nanocarriers for Intracellular Protein Delivery. Chem 
Soc Rev. 2011; 40:3638–3655. [PubMed: 21566806] 
16. Carter PJ. Introduction to Current and Future Protein Therapeutics: A Protein Engineering 
Perspective. Exp Cell Res. 2011; 317:1261–1269. [PubMed: 21371474] 
17. Patel S, Jung D, Yin PT, Carlton P, Yamamoto M, Bando T, Sugiyama H, Lee KB. NanoScript: A 
Nanoparticle-Based Artificial Transcription Factor for Effective Gene Regulation. ACS Nano. 
2014; 8:8959–8967. [PubMed: 25133310] 
18. Dervan PB, Edelson BS. Recognition of the DNA Minor Groove by Pyrrole-Imidazole Polyamides. 
Curr Opin Struct Biol. 2003; 13:284–299. [PubMed: 12831879] 
19. Gottesfeld JM, Neely L, Trauger JW, Baird EE, Dervan PB. Regulation of Gene Expression by 
Small Molecules. Nature. 1997; 387:202–205. [PubMed: 9144294] 
20. Lassar AB, Buskin JN, Lockshon D, Davis RL, Apone S, Hauschka SD, Weintraub H. MyoD Is a 
Sequence-Specific DNA Binding Protein Requiring a Region of Myc Homology To Bind to the 
Muscle Creatine Kinase Enhancer. Cell. 1989; 58:823–831. [PubMed: 2550138] 
21. Morinaga H, Bando T, Takagaki T, Yamamoto M, Hashiya K, Sugiyama H. Cysteine Cyclic 
Pyrrole–Imidazole Polyamide for Sequence-Specific Recognition in the DNA Minor Groove. J 
Am Chem Soc. 2011; 133:18924–18930. [PubMed: 21985474] 
22. Nyanguile O, Uesugi M, Austin DJ, Verdine GL. A Nonnatural Transcriptional Coactivator. Proc 
Natl Acad Sci US A. 1997; 94:13402–13406.
23. Cantin GT, Stevens JL, Berk AJ. Activation Domain–Mediator Interactions Promote Transcription 
Preinitiation Complex Assembly on Promoter DNA. Proc Natl Acad Sci US A. 2003; 100:12003–
12008.
24. Krpetić Ž, Saleemi S, Prior IA, Sée V, Qureshi R, Brust M. Negotiation of Intracellular Membrane 
Barriers by TAT-Modified Gold Nanoparticles. ACS Nano. 2011; 5:5195–5201. [PubMed: 
21609028] 
25. Rahme K, Chen L, Hobbs RG, Morris MA, O’Driscoll C, Holmes JD. Pegylated Gold 
Nanoparticles: Polymer Quantification as a Function of PEG Lengths and Nanoparticle 
Dimensions. RSC Adv. 2013; 3:6085–6094.
26. Tkachenko AG, Xie H, Coleman D, Glomm W, Ryan J, Anderson MF, Franzen S, Feldheim DL. 
Multifunctional Gold Nanoparticle–Peptide Complexes for Nuclear Targeting. J Am Chem Soc. 
2003; 125:4700–4701. [PubMed: 12696875] 
Patel et al. Page 9
ACS Nano. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
27. Hinterwirth H, Kappel S, Waitz T, Prohaska T, Lindner W, Lämmerhofer M. Quantifying Thiol 
Ligand Density of Self-Assembled Monolayers on Gold Nanoparticles by Inductively Coupled 
Plasma–Mass Spectrometry. ACS Nano. 2013; 7:1129–1136. [PubMed: 23331002] 
28. Iversen TG, Skotland T, Sandvig K. Endocytosis and Intracellular Transport of Nanoparticles: 
Present Knowledge and Need for Future Studies. Nano Today. 2011; 6:176–185.
29. Görlich D, Mattaj IW. Nucleocytoplasmic Transport. Science. 1996; 271:1513–1519. [PubMed: 
8599106] 
30. Gimble JM, Katz AJ, Bunnell BA. Adipose-Derived Stem Cells for Regenerative Medicine. Circ 
Res. 2007; 100:1249–1260. [PubMed: 17495232] 
31. Cardozo AJ, Gómez DE, Argibay PF. Neurogenic Differentiation of Human Adipose-Derived Stem 
Cells: Relevance of Different Signaling Molecules, Transcription Factors, and Key Marker Genes. 
Gene. 2012; 511:427–436. [PubMed: 23000064] 
32. Fan J, Park H, Tan S, Lee M. Enhanced Osteogenesis of Adipose Derived Stem Cells with Noggin 
Suppression and Delivery of BMP-2. PLoS One. 2013; 8:e72474. [PubMed: 23977305] 
33. Berkes CA, Tapscott SJ. MyoD and the Transcriptional Control of Myogenesis. Semin Cell Dev 
Biol. 2005; 16:585–595. [PubMed: 16099183] 
34. Andres V, Walsh K. Myogenin Expression, Cell Cycle Withdrawal, and Phenotypic Differentiation 
are Temporally Separable Events that Precede Cell Fusion upon Myogenesis. J Cell Biol. 1996; 
132:657–666. [PubMed: 8647896] 
35. Fougerousse F, Edom-Vovard F, Merkulova T, Ott MO, Durand M, Butler-Browne G, Keller A. 
The Muscle-Specific Enolase is an Early Marker of Human Myogenesis. J Muscle Res Cell Motil. 
2001; 22:535–544. [PubMed: 12038587] 
36. Nitahara-Kasahara Y, Hayashita-Kinoh H, Ohshima-Hosoyama S, Okada H, Wada-Maeda M, 
Nakamura A, Okada T, Takeda S. Long-Term Engraftment of Multipotent Mesenchymal Stromal 
Cells That Differentiate To Form Myogenic Cells in Dogs with Duchenne Muscular Dystrophy. 
Mol Ther. 2012; 20:168–177. [PubMed: 21934652] 
37. Kang B, Mackey MA, El-Sayed MA. Nuclear Targeting of Gold Nanoparticles in Cancer Cells 
Induces DNA Damage, Causing Cytokinesis Arrest and Apoptosis. J Am Chem Soc. 2010; 
132:1517–1519. [PubMed: 20085324] 
38. Sakhtianchi R, Minchin RF, Lee K-B, Alkilany AM, Serpooshan V, Mahmoudi M. Exocytosis of 
Nanoparticles from Cells: Role in Cellular Retention and Toxicity. Adv Colloid Interface Sci. 
2013; 201–202:18–29.
39. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, et al. 
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming 
Proteins. Cell Stem Cell. 2009; 4:472–476. [PubMed: 19481515] 
40. Hannon GJ. RNA Interference. Nature. 2002; 418:244–251. [PubMed: 12110901] 
41. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AKR, Han MS, Mirkin CA. Oligonucleotide-
Modified Gold Nanoparticles for Intracellular Gene Regulation. Science. 2006; 312:1027–1030. 
[PubMed: 16709779] 
42. Pandian GN, Taniguchi J, Junetha S, Sato S, Han L, Saha A, AnandhaKumar C, Bando T, Nagase 
H, Vaijayanthi T, et al. Distinct DNA-Based Epigenetic Switches Trigger Transcriptional 
Activation of Silent Genes in Human Dermal Fibroblasts. Sci Rep. 2014:4.
43. Estefanía MM, Ganier O, Hernández P, Schvartzman JB, Mechali M, Krimer DB. DNA 
Replication Fading as Proliferating Cells Advance in Their Commitment to Terminal 
Differentiation. Sci Rep. 2012:2.
Patel et al. Page 10
ACS Nano. Author manuscript; available in PMC 2018 February 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Schematic representation of NanoScript-MRF emulating transcription factor proteins. (a) 
Individual domains of TF proteins (such as the CPP, AD, and DBD) are mimicked through 
small molecules and peptide counterparts. By assembling these specific biomolecules on 
AuNPs, the NanoScript platform is fabricated. (b) Myogenic regulatory factors, which 
regulate muscle cell differentiation, are TFs that interact with DNA to regulate gene 
expression for muscle-specific genes. The NanoScript-MRF platform, which mimics MRFs, 
can perform the same function of expressing muscle-specific genes. (c) Transfection of 
NanoScript-MRF into adipose-derived mesenchymal stem cells induces activation of MRFs, 
which guides their differentiation into muscle cells.
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Figure 2. 
MRF-DBD polyamide has high binding affinity for the target sequence. (a) MRF-DBD, with 
imidazole (red) and pyrrole (blue) motifs arranged in a specific sequence to complement the 
MRF response element (N = any base pair). (b) Sensorgrams show the interaction of varying 
polyamide MRF-DBD concentrations with the complementary hairpin DNA. The 
equilibrium constant (KD), which is indicative of the binding affinity, was determined by the 
ratio of the dissociation constant (kd) to the association constant (ka).
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Figure 3. 
Conjugation of molecules and construction of NanoScript-MRF. (a) Each biomolecule (AD, 
CPP, and MRF-DBD) was conjugated to the thiol-PEG-carboxy linker molecule. (b) Three 
PEG-conjugated biomolecules were assembled on AuNPs via thiol moieties to construct the 
NanoScript-MRF, and (c) characterization using a zetasizer confirmed the diameter and 
surface charge of NanoScript.
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Figure 4. 
NanoScript-MRF generates muscle cells as evidenced by phenotypic and genotypic changes. 
(a) Differentiation timeline of ADMSCs being treated with NanoScript-MRF. (b) Phase and 
fluorescence images of ADMSCs that were fixed and stained on day 7. The untreated 
control ADMSCs (top row) and the NanoScript-MRF-treated ADMSCs (bottom row) were 
stained for muscle-specific markers such as myogenin (green, middle column) and myosin 
(red, right column) and the nucleus marker, DAPI (blue). (c) Magnified phase and 
fluorescence image of a multinucleated muscle cell shows the development of myofibrils 
(indicated with white arrows). A fluorescence intensity profile of the induced muscle cell 
shows the distribution of six distinct peaks for individual myofibrils (scale bar = 20 μm).
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Figure 5. 
NanoScript-MRF initiates transcription and activation of myogenic genes. (a) After 7 days 
post-treatment with NanoScript-MRF, qPCR analysis reveals overexpression of targeted 
MRFs as well as significant expression of the late-stage myogenic gene MYH1by 
NanoScript-MRF (red) as compared to the untreated control (gray). (b) Multipotent genes of 
ADMSCs were down-regulated as compared to untreated control cells, thus indicating that 
stem properties of ADMSCs are repressed when myogenic genes are overexpressed. Error 
bars are from three independent trials, and mRNA expression is represented as a fold change 
compared to the control.
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Figure 6. 
NanoScript mimics the gene-regulating function TF proteins and is excreted after inducing 
differentiation. (a) MyoD-TF protein was delivered using commercial transfection kits, and 
after 7 days, the gene expression of MyoD was evaluated. At a similar concentration (1 nM 
= 10 μg/mL), NanoScript-MRF triggers moderately higher levels of MyoD expression. The 
MyoD expression induced by NanoScript is identical to that in Figure 5a. (b) Schematic 
representation of NanoScript being taken up by cells through a mechanism called 
endocytosis and NanoScript being cleared from cells through a mechanism called 
exocytosis. (c) NanoScript-MRF was transfected on day 0 and day 2, and the gold content 
within the cells was quantified at various time points using inductively coupled plasma 
optical emission spectrometry (ICP-OES). The number of NanoScript particles remaining 
inside the cell was determined by quantifying the number of gold nanoparticles using a 
standard curve and then dividing by the number of cells. Based on microscope visualization, 
the cells stopped proliferating during the differentiation period, which is a phenomenon 
supported by literature.43 The sharp peaks at day 0 and day 2 correlate to the delivery of 
NanoScript, and approximately 95% of NanoScript-MRF is cleared by day 7 (calculated by 
dividing the number of particles on day 7 by the highest peak on day 2). Error bars are from 
three independent experiments.
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